Gallbladder Cancer
📧 Sign up to get email alerts when something new happens for Gallbladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line [Phase 2]
Phase 2 trial comparing mFOLFOX vs. mFOLFIRI in advanced or recurrent biliary tract cancer refractory to first-line therapy has completed.
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating first-line gemcitabine, cisplatin, and MEK162 in advanced biliary tract carcinoma has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Adjuvant Immunotherapy Combined With Chemoradiation for Patients With High-risk reseCtable Extrahepatic chOlangiocaRcinoma and gallblaDder Cancer [Phase 2]
A Phase 2 clinical trial evaluating adjuvant immunotherapy in combination with chemoradiation for high-risk resectable biliary tract cancers…
-
CLINICAL_TRIALS trial_result · 2020-01-28Clinical Trial Update: Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers [Phase 3]
Phase 3 trial comparing active symptom control alone versus with mFOLFOX chemotherapy for locally advanced or metastatic biliary tract cance…
-
CLINICAL_TRIALS trial_result · 2019-12-09Clinical Trial Update: Clinical Study on the First-line Treatment of Advanced Biliary System Tumors With Tripley Monoclonal Antibody Combined With GEMOX Regimen [Phase 2]
Phase 2 clinical trial evaluating Tripley monoclonal antibody combined with GEMOX as first-line treatment for advanced biliary tract tumors.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: Efficacy and Safety Study of Nab-Paclitaxel Combined With Cisplatin in Second or Later-Line Treatment in Advanced Biliary Tract Cancers [Phase 2]
Phase 2 trial evaluating nab-paclitaxel with cisplatin in advanced biliary tract cancers; efficacy and safety updates are reported.
-
CLINICAL_TRIALS trial_result · 2019-10-01Clinical Trial Update: TAS-102 in Treating Advanced Biliary Tract Cancers [Phase 2]
A Phase 2 clinical trial update for TAS-102 in advanced biliary tract cancers (cholangiocarcinoma and gallbladder cancer) has completed with…
-
CLINICAL_TRIALS trial_result · 2019-05-21Clinical Trial Update: Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma [Phase 3]
Phase 3 trial comparing GEMOX to XELOX in advanced biliary tract cancer; status is unknown.
-
CLINICAL_TRIALS trial_result · 2019-05-15Clinical Trial Update: CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating CPI-613 in advanced or metastatic biliary tract cancers, including cholangiocarcinoma and unresectable o…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Efficacy and Safety of Endobiliary Radiofrequency Ablation by Using a Novel RF Catheter (ELRA®) on Maintaining the Patency of Endobiliary Metal Drainage in Patients With Malignant Biliary Strictures : A Double-arm Comparable Study [NA]
This clinical trial update discusses the efficacy and safety of a novel endobiliary radiofrequency ablation catheter (ELRA) used to maintain…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma [Phase 2]
Phase 2 clinical trial evaluating FOLFIRINOX chemotherapy in advanced or recurrent extrahepatic cholangiocarcinoma and gallbladder carcinoma…
-
CLINICAL_TRIALS trial_result · 2018-12-07Clinical Trial Update: Molecularly Target Therapy With FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma [Phase 2]
Phase 2 trial exploring molecularly targeted therapy with FOLFIRINOX in advanced or recurrent extrahepatic cholangiocarcinoma and gallbladde…
-
CLINICAL_TRIALS trial_result · 2018-07-31Clinical Trial Update: A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is investigating cannabidiol for efficacy in multiple myeloma, glioblastoma, and various gastrointestinal cancers…
-
CLINICAL_TRIALS trial_result · 2018-05-07Clinical Trial Update: Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma [Phase 2]
This report covers a Phase 2 trial of GEMOX (gemcitabine plus oxaliplatin) for advanced or recurrent extrahepatic cholangiocarcinoma and gal…
-
CLINICAL_TRIALS trial_result · 2017-08-10Clinical Trial Update: Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery [Phase 2]
Phase 2 trial updates on trametinib or combination chemotherapy for refractory or unresectable biliary tract and gallbladder cancers; comple…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer [Phase 1]
Phase 1 study evaluating the safety, tolerability, and preliminary efficacy of a triplet regimen of gemcitabine hydrochloride, oxaliplatin, …
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder [Phase 2]
Phase 2 trial evaluating Bortezomib in unresectable or metastatic adenocarcinoma of the bile duct or gallbladder was terminated; results wer…
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder
A completed clinical trial investigated the use of isosulfan blue for visceral lymphatic mapping in patients with cancers of the pancreas, c…
-
CLINICAL_TRIALS trial_result · 2017-03-29Clinical Trial Update: Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers [Phase 2]
Phase 2 trial of cediranib maleate in combination chemotherapy for advanced biliary cancers was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer [Phase 2]
This Phase 2 trial update reports the termination of a study evaluating palonosetron hydrochloride for preventing radiation-induced nausea a…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery [Phase 3]
A Phase 3 trial evaluating adjuvant gemcitabine hydrochloride with oxaliplatin versus observation in biliary tract cancer after surgical res…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy [Phase 1]
Phase 1 clinical trial evaluating a triple regimen of everolimus, gemcitabine hydrochloride, and cisplatin in adults with unresectable solid…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer [Phase 1, Phase 2]
Phase 1/2 trial update of gemcitabine plus pemetrexed disodium in unresectable or metastatic biliary tract cancers, including gallbladder ca…
-
CLINICAL_TRIALS trial_result · 2016-12-07Clinical Trial Update: Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer [Phase 2]
Phase 2 clinical trial evaluating combination chemotherapy in unresectable or metastatic biliary tract and gallbladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-09-22Clinical Trial Update: S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct [Phase 2]
Phase 2 trial S0809 evaluated capecitabine and gemcitabine with radiation therapy in cholangiocarcinoma of the gallbladder or bile duct. The…